Breaking Through on Biosimilars
Take a deep dive into the policy and regulatory science challenges facing the biosimilars market in the United States. We will discuss the significant role biosimilars play in increasing patient access to more affordable medicines and factors affecting the future of sustainable biosimilar competition and development. Additionally, a diverse group of stakeholders will share their perspectives on the evolving biosimilars marketplace and their current thinking of how biosimilar research and development is changing.
